サンプル依頼リスト カート
  • English
  • Korean
表紙：羊膜製品市場- 世界の規模、シェア、動向分析、機会、予測レポート、2019-2030年
市場調査レポート
商品コード
1410992

羊膜製品市場- 世界の規模、シェア、動向分析、機会、予測レポート、2019-2030年

Amniotic Products Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type ; By End User ; By Application ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
羊膜製品市場- 世界の規模、シェア、動向分析、機会、予測レポート、2019-2030年
出版日: 2024年01月11日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

羊膜製品の世界市場規模は2030年までに13億米ドルを突破、2024-2030年のCAGRは8.56％で拡大へ

羊膜製品の利点に対する認識が高まり、羊膜製品の研究開発への投資が増加していることから、世界の羊膜製品市場は牽引力を増しています。

戦略コンサルティングおよび市場調査の大手企業であるBlueWeave Consultingは、最近の調査で、羊膜製品の世界市場規模を2023年に8億1,040万米ドルと推定しました。2024年から2030年までの予測期間中、BlueWeaveは羊膜製品の世界市場規模がCAGR 8.56%で成長し、2030年には13億2,620万米ドルに達すると予測しています。皮膚や目の疾患の治療における羊膜製品の使用の増加や、潰瘍などの慢性創傷の発生率の増加が、世界の羊膜製品市場の重要な促進要因となっています。さらに、分析期間中、羊膜製品に関する研究開発プログラムの増加が市場成長を促進すると予想されます。

本レポートの詳細な分析により、成長の可能性、今後の動向、世界の羊膜製品市場に関する情報を提供します。また、総市場規模の予測を促進する要因も明らかにしています。当レポートは、世界の羊膜製品市場における最近の技術動向や業界考察を提供し、意思決定者が健全な戦略的意思決定を行えるよう支援することをお約束します。さらに、市場の成長促進要因・課題・競争力学についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の羊膜製品市場に関する洞察

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 慢性創傷の罹患率の増加
      • 羊膜製品の利点に対する認識の高まり
      • 羊膜製品の研究開発への投資を拡大
    • 抑制要因
      • 羊膜の入手可能性は限られている
      • 代替創傷治療製品との競合
    • 機会
      • 再生医療への応用拡大
      • 新興市場での需要の拡大
    • 課題
      • 羊膜製品の品質と一貫性の維持
      • 羊膜製品についてのヘルスケア専門家への教育
  • 技術の進歩/最近の開発
  • 消費者の行動と洞察
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の羊膜製品市場概要

  • 市場規模と予測、2019～2030年
    • 金額別
  • 市場シェアと予測
    • タイプ別
      • 凍結保存羊膜
      • 脱水羊膜
    • エンドユーザー別
      • 病院および外来手術センター
      • その他
    • 用途別
      • 創傷ケア
      • 整形外科
      • 眼科
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東およびアフリカ（MEA）

第5章 北米の羊膜製品市場

  • 市場規模と予測、2019～2030年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • エンドユーザー別
    • 用途別
    • 国別
      • 米国
      • カナダ

第6章 欧州の羊膜製品市場

  • 市場規模と予測、2019～2030年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • エンドユーザー別
    • 用途別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他

第7章 アジア太平洋の羊膜製品市場

  • 市場規模と予測、2019～2030年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • エンドユーザー別
    • 用途別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • その他

第8章 ラテンアメリカの羊膜製品市場

  • 市場規模と予測、2019～2030年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • エンドユーザー別
    • 用途別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • その他

第9章 中東およびアフリカの羊膜製品市場

  • 市場規模と予測、2019～2030年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • エンドユーザー別
    • 用途別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界の羊膜製品市場シェア分析、2023年
  • 経営パラメータによる競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 地政学的な緊張が世界の羊膜製品市場に与える影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

  • MiMedx Group
  • Organogenesis
  • Smith &Nephew
  • Integra LifeSciences
  • Amniox Medical
  • AmnioTech
  • Skye Biologics
  • Applied Biologics
  • TissueTech
  • Katena Products
  • その他の主要企業

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC24030

Global Amniotic Products Market Size Set to Surpass USD 1.3 Billion by 2030, Expanding at CAGR of 8.56% During 2024-2030.

Global Amniotic Products Market is gaining traction because of the growing awareness about the benefits of amniotic products and increasing investments in amniotic product research and development.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Amniotic Products Market size at USD 810.4 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Amniotic Products Market size to grow at a CAGR of 8.56% reaching a value of USD 1,326.2 million by 2030. The increasing use of amniotic products in the treatment of skin and eye conditions, as well as the growing incidence of chronic wounds, such as ulcers, are significant driving factors for the Global Amniotic Products Market. Moreover, over the period in analysis, it is expected that growing number of research and development programs on amniotic products will propel market growth.

Opportunity: Increasing number of amniotic product launches

The rising adoption of amniotic products in the healthcare sector owing to their therapeutic properties is also influencing product launches and research and development programs in the field. For instance, Amnio Technology, a United States-based developer and manufacturer of amnion-derived technologies, announced the launch of two new PalinGen membrane products, PalinGen Dual-Layer Membrane, and Dual Layer PalinGen X-Membrane. Versea Health, Inc., another US-based pharmaceutical products company, is launching Biovance 3L ocular tri-layer human amniotic membrane.

Global Amniotic Products Market - By End User

Based on end user, the Global Amniotic Products Market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment holds the largest share of the Global Amniotic Products Market by end user. The growth of the segment is mainly attributed to the high number of outpatient visits for wound treatment and surgical procedures. Amniotic membranes are mostly obtained at hospitals for use in tendon and ligament repair or for ophthalmic purposes. Hospital billing and reimbursement for these products are also easily obtained, which is a key factor contributing to the growth of the hospitals segment.

Impact of Escalating Geopolitical Tensions on Global Amniotic Products Market

The escalating geopolitical tensions are negatively impacting the growth of the Global Amniotic Products Market. Ukraine has a flourishing medical tourism sector. The country offers cost-effective quality healthcare. Ukraine's medical sector was increasingly becoming the hub for specialized treatments not readily available in other countries. However, with Russia's war on Ukraine, medical tourism dwindled, and the number of surgeries performed in the country declined at a staggering rate owing to the sensitive situation in the country and a lack of resources. It resulted in a significant decline in the demand for amniotic products for healthcare purposes as well as hindered research and development activities, limiting its market growth.

Global Amniotic Products Market - By Region

The in-depth research report on the Global Amniotic Products Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Amniotic Products Market. The rising healthcare expenditure, coupled with the increasing prevalence of chronic wounds and diabetes, as well as the high concentration of amniotic product manufacturers, are directly influencing market growth. However, the Asia Pacific region is projected to register a high growth rate during the forecast period owing to the growing geriatric population in East Asian countries, including Japan and South Korea.

Competitive Landscape

Major players operating in the Global Amniotic Products Market include: MiMedx Group, Organogenesis, Smith & Nephew, Integra LifeSciences, Amniox Medical, AmnioTech, Skye Biologics, Applied Biologics, TissueTech, and Katena Products. These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Amniotic Products Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Amniotic Products Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Amniotic Products Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Amniotic Products Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Chronic Wounds
      • 3.2.1.2. Growing Awareness of the Benefits of Amniotic Products
      • 3.2.1.3. Increasing Investments in Amniotic Product Research and Development
    • 3.2.2. Restraints
      • 3.2.2.1. Limited Availability of Amniotic Membranes
      • 3.2.2.2. Competition from Alternative Wound Care Products
    • 3.2.3. Opportunities
      • 3.2.3.1. Expanding Applications in Regenerative Medicine
      • 3.2.3.2. Growing Demand in Emerging Markets
    • 3.2.4. Challenges
      • 3.2.4.1. Maintaining the Quality and Consistency of Amniotic Products
      • 3.2.4.2. Educating Healthcare Professionals about Amniotic Products
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Consumer Behavior and Insights
  • 3.5. Regulatory Framework
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Intensity of Rivalry

4. Global Amniotic Products Market Overview

  • 4.1. Market Size & Forecast, 2019-2030
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Cryopreserved Amniotic Membrane
      • 4.2.1.2. Dehydrated Amniotic Membrane
    • 4.2.2. By End User
      • 4.2.2.1. Hospitals & Ambulatory Surgical Centers
      • 4.2.2.2. Others
    • 4.2.3. By Application
      • 4.2.3.1. Wound Care
      • 4.2.3.2. Orthopedics
      • 4.2.3.3. Ophthalmology
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Amniotic Products Market

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By End User
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Type
      • 5.2.4.1.2. By End User
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Type
      • 5.2.4.2.2. By End User
      • 5.2.4.2.3. By Application

6. Europe Amniotic Products Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By End User
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By End User
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Type
      • 6.2.4.3.2. By End User
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Type
      • 6.2.4.4.2. By End User
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Type
      • 6.2.4.5.2. By End User
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Type
      • 6.2.4.6.2. By End User
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Type
      • 6.2.4.7.2. By End User
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Type
      • 6.2.4.8.2. By End User
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Type
      • 6.2.4.9.2. By End User
      • 6.2.4.9.3. By Application

7. Asia Pacific Amniotic Products Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By End User
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By End User
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By End User
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By End User
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By End User
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By End User
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By End User
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By End User
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By End User
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Type
      • 7.2.4.10.2. By End User
      • 7.2.4.10.3. By Application

8. Latin America Amniotic Products Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By End User
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By End User
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By End User
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By End User
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By End User
      • 8.2.4.5.3. By Application

9. Middle East & Africa Amniotic Products Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By End User
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By End User
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By End User
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By End User
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By End User
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Type
      • 9.2.4.6.2. By End User
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Type
      • 9.2.4.7.2. By End User
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Type
      • 9.2.4.8.2. By End User
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Amniotic Products Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Geopolitical Tension on Global Amniotic Products Market

12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. MiMedx Group
  • 12.2. Organogenesis
  • 12.3. Smith & Nephew
  • 12.4. Integra LifeSciences
  • 12.5. Amniox Medical
  • 12.6. AmnioTech
  • 12.7. Skye Biologics
  • 12.8. Applied Biologics
  • 12.9. TissueTech
  • 12.10. Katena Products
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations